(5β,9R,10α)-15,16-Epoxylabda-8(17),13(16),14-trien-19-oic acid (10267-14-8)

Other Product

• (4R,5β,8α,9β,10α,12α)-9-Hydroxy-15-oxoatis-16-en-18-oic acid
• 16-Hydroxy-8(17),13- labdadien-15,16-olid-19-oic acid
• (5β,9α,10α)-Labd-8(17)-en-15-oic acid methyl ester
• (13E)-19-Norlabda-8(17),13-dien-15-oic acid
• 13-Hydroxylabda-8(17),14-diene-19-oic acid
• dynorphin A (1-13), Tyr(14)-Leu(15)-Phe(16)-Asn(17)-Gly(18)-Pro(19)-
• 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
• 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
• 1/C17H18OS/c1-4-11-7-5-8-12-13-9-6-10-14(17(2,3)18)16(13)19-15(11)12/h5-10,18H,4H2,1-3H
• 3,6,9,12-Tetraoxa-15-azanonadecan-19-oic acid, 1-hydroxy-13-methyl-16-oxo-17-sulfo-, 15-coco alkyl derivs., disodium salts
• 1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
• 1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
• 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
• 1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
• 1/C19H20O5/c1-11(2)7-18(21)24-19(3,4)16-9-13-8-12-5-6-17(20)23-14(12)10-15(13)22-16/h5-8,10,16H,9H2,1-4H
• 1/C18H30O4/c1-4-5-6-7-15(19)13-16(20)10-8-14-9-11-17(21-2)18(12-14)22-3/h9,11-12,15-16,19-20H,4-8,10,13H2,1-3H3/t15-,16-/m0/s
• 16-Nor-15-oxoabieta-8,11,13-trien-18-oic acid
• (4R,5β,8α,9β,10α,12α)-9,15β-Dihydroxyatis-16-en-18-oic acid
• (5β,8R,9β,10α,12S)-7α-Hydroxyatis-16-en-18-oic acid
• 1/C16H15FN2O3S/c1-23(21,22)19-14-5-3-2-4-13(14)18-16(20)10-15(19)11-6-8-12(17)9-7-11/h2-9,15H,10H2,1H3,(H,18,20